Wouldn’t be surprised to see many GLP-1 based economies struggle after May 21st once compounding goes away. 

This includes many ‘Longevity’ companies whose main source of revenue are compounded GLP-1 meds.

Physician always trying to learn, passionate about healthspan and precision medicine.

omarsaleem.xyz

wait what’s happening may 21, i thought they were already sketchy bc of the shortage being officially over?

Yup? Tirzepatide was already banned, but May 21 is when compounded semaglutide will be off the list so has to be ceased production. 
Most compounding clinics use semaglutide as it’s cheaper and had a more widespread economy (B12+semaglutide), (rapamycin+semaglutide), (nlrp3 + semaglutide) in the longevity community.